Observational infant exploratory [14C]-paracetamol pharmacokinetic microdose/therapeutic dose study with accelerator mass spectrometry bioanalysis-Reference-Cited by-同舟云学术

Observational infant exploratory [14C]-paracetamol pharmacokinetic microdose/therapeutic dose study with accelerator mass spectrometry bioanalysis

Published:2015-06-01 Issue:1 Volume:80 Page:157-167
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Garner Colin R.¹²,Park Kevin B.³,French Neil S.³,Earnshaw Caroline³,Schipani Alessandro³,Selby Andrew M.⁴,Byrne Lindsay⁴,Siner Sarah⁴,Crawley Francis P.⁵,Vaes Wouter H. J.⁶,van Duijn Esther⁶,deLigt Rianne⁶,Varendi Heili⁷,Lass Jane⁷,Grynkiewicz Grzegorz⁸,Maruszak Wioletta⁸,Turner Mark A.⁹

Affiliation:

1. Hull York Medical School; University of York; Heslington York YO1 5DD United Kingdom

2. United Kingdom and Garner Consulting; 5 Hall Drive, Sand Hutton York YO41 1LA United Kingdom

3. Institute of Translational Medicine; University of Liverpool; Crown Street Liverpool L69 3BX United Kingdom

4. Alder Hey Children's NHS Foundation Trust; Eaton Road, West Derby Liverpool L12 2AP United Kingdom

5. Good Clinical Practice Alliance - Europe; Schoolbergenstraat 47 BE-3010 Kessel-Lo Belgium

6. TNO Zeist; Utrechtseweg 48, PO Box 360 3700 AJ Zeist The Netherlands

7. Department of Paediatrics; Tartu University Hospital, University of Tartu; 51014 Tartu Estonia

8. Pharmaceutical Research Institute; 8 Rydygiera Street 01-793 Warsaw Poland

9. Department of Women's and Children's Health, Institute of Translational Medicine; University of Liverpool, University of Liverpool; Liverpool L69 3BX United Kingdom

Funder

Medical Research Council

Estonian Science Foundation

Narodowym Centrum Bada I Rozwojugrant

ZonMW

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12597/fullpdf

Reference44 articles.

1. Antibiotic dosing in children in Europe: can we grade the evidence from pharmacokinetic/pharmacodynamic studies-and when is enough data enough?;Barker;Curr Opin Infect Dis,2012

2. FDA, U.S. Guidance for industry, pediatric study plans:content of and process for submitting initial pediatric study plans and amended pediatric study plans 2013 http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM360507.pdf

3. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations;Bartelink;Clin Pharmacokinet,2006

4. Understanding the relative roles of pharmacogenetics and ontogeny in pediatric drug development and regulatory science;Leeder;J Clin Pharmacol,2010

5. Developmental expression of drug metabolizing enzymes: impact on disposition in neonates and young children;Hines;Int J Pharm,2013

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategic, feasibility, economic, and cultural aspects of phase 0 approaches;Clinical and Translational Science;2022-04-21

2. Current knowledge, challenges and innovations in developmental pharmacology: A combined conect4children Expert Group and European Society for Developmental, Perinatal and Paediatric Pharmacology White Paper;British Journal of Clinical Pharmacology;2021-07-23

3. Phase 0/microdosing approaches: time for mainstream application in drug development?;Nature Reviews Drug Discovery;2020-09-08

4. Innovative approaches and recent advances in the study of ontogeny of drug metabolism and transport;British Journal of Clinical Pharmacology;2020-08-26

5. Proof of Concept: First Pediatric [ 14 C]microtracer Study to Create Metabolite Profiles of Midazolam;Clinical Pharmacology & Therapeutics;2020-06-27